Okay, well, they did this interesting
(PubMed) Rhodes A, Evans LE, Alhazzani W, et al
They preserve muscle function by improving insulin resistance and metabolic health
Wegovy is an injectable prescription medication that contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Participants had a minimum of 6 heavy drinking days during the 30 before the beginning of the trial (the average number was 17), and 85% met criteria for severe AUD
The cysteine residues of PDI family members such as PDI, ERp57, and ERp72 contain redox-sensitive side chains and may become oxidized during redox dysregulation (Valle and Carr, 2017)